🌎 Affirm Upgraded, Autoliv Upgraded, Carrier Global Upgraded and more..
RJ Hamster
Advertisements
Ratings changes for First Financial Northwest, Trinity Biotech, Seres Therapeutics, Athersys, Aspen Technology, ODP, First Northwest Bancorp and more…Upgrade to MarketBeat All Access to get early delivery, personalized stock alerts, portfolio monitoring tools, and more. Start Your Free Trial.
How Exec Order 14179 Could Change Social Security Forever (ad)
President Trump’s inner circle has a plan that could radically change how Social Security works. In fact, just days after taking office, President Trump signed Executive Order 14179 – giving his team new powers to permanently reset how many key federal agencies work. That reset is now ready to begin – and it’s critical you start preparing your money immediately.
In fact, for reasons explained here, we’re expecting the next huge announcement before July 22nd at the latest.
Apple Inc. (NASDAQ:AAPL) announced a quarterly dividend on Thursday, May 1st. Stockholders of record on Monday, May 12th will be paid a dividend of 0.26 per share by the iPhone maker on Thursday, May 15th. This represents a $1.04 dividend on an annualized basis and a dividend yield of 0.52%. The ex-dividend date is Monday, May 12th. This is a 4.0% increase from Apple’s previous quarterly dividend of $0.25.
insider Jennifer Newstead sold 921 shares of the stock in a transaction dated Tuesday, May 6th. The shares were sold at an average price of $592.52, for a total transaction of $545,710.92. Following the sale, the insider now directly owns 25,656 shares in the company, valued at $15,201,693.12. This represents a 3.47 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website.
Affirm (NASDAQ:AFRM) was upgraded by analysts at Susquehanna from a “neutral” rating to a “positive” rating. They now have a $65.00 price target on the stock. This represents a 30.7% upside from the current price of $49.72.
Autoliv (NYSE:ALV) was upgraded by analysts at BNP Paribas Exane from a “neutral” rating to an “outperform” rating. They now have a $123.00 price target on the stock. This represents a 25.3% upside from the current price of $98.18.
Carrier Global (NYSE:CARR) was upgraded by analysts at Northcoast Research from a “neutral” rating to a “buy” rating. They now have a $85.00 price target on the stock. This represents a 19.4% upside from the current price of $71.17.
National Vision (NASDAQ:EYE) was upgraded by analysts at Citigroup Inc. from a “neutral” rating to a “buy” rating. They now have a $21.00 price target on the stock, up previously from $13.00. This represents a 24.1% upside from the current price of $16.93.
Haleon (NYSE:HLN) was upgraded by analysts at Morgan Stanley from an “equal weight” rating to an “overweight” rating. They now have a $11.25 price target on the stock. This represents a 4.1% upside from the current price of $10.81.
nLIGHT (NASDAQ:LASR) was upgraded by analysts at Craig Hallum from a “hold” rating to a “buy” rating. They now have a $14.00 price target on the stock. This represents a 29.0% upside from the current price of $10.86.
Lyft (NASDAQ:LYFT) was upgraded by analysts at The Goldman Sachs Group, Inc. from a “neutral” rating to a “buy” rating. They now have a $20.00 price target on the stock. This represents a 30.1% upside from the current price of $15.38.
Microchip Technology (NASDAQ:MCHP) was upgraded by analysts at Bank of America Co. from an “underperform” rating to a “neutral” rating. They now have a $56.00 price target on the stock. This represents a 0.9% upside from the current price of $55.52.
Owens Corning (NYSE:OC) was upgraded by analysts at Wolfe Research from a “peer perform” rating to an “outperform” rating.The current price is $138.89.
Ouster (NYSE:OUST) was upgraded by analysts at Westpark Capital from a “hold” rating to a “buy” rating. They now have a $13.68 price target on the stock. This represents a 28.0% upside from the current price of $10.69.
PTC Therapeutics (NASDAQ:PTCT) was upgraded by analysts at Bank of America Co. from a “neutral” rating to a “buy” rating. They now have a $68.00 price target on the stock, up previously from $55.00. This represents a 49.4% upside from the current price of $45.52.
Rockwell Automation (NYSE:ROK) was upgraded by analysts at TD Cowen from a “sell” rating to a “hold” rating. They now have a $275.00 price target on the stock. This represents a 6.3% downside from the current price of $293.42.
GeneDx (NASDAQ:WGS) was upgraded by analysts at Jefferies Financial Group Inc. from a “hold” rating to a “buy” rating. They now have a $80.00 price target on the stock. This represents a 32.5% upside from the current price of $60.40.
Apellis Pharmaceuticals (NASDAQ:APLS) was downgraded by analysts at Bank of America Co. from a “buy” rating to a “neutral” rating. They now have a $23.00 price target on the stock, down previously from $41.00. This represents a 30.3% upside from the current price of $17.65.
Apellis Pharmaceuticals (NASDAQ:APLS) was downgraded by analysts at Raymond James from a “strong-buy” rating to an “outperform” rating. They now have a $52.00 price target on the stock. This represents a 194.6% upside from the current price of $17.65.
Cytek Biosciences (NASDAQ:CTKB) was downgraded by analysts at TD Cowen from a “buy” rating to a “hold” rating. They now have a $4.00 price target on the stock. This represents a 22.3% upside from the current price of $3.27.
DocGo (NASDAQ:DCGO) was downgraded by analysts at BTIG Research from a “buy” rating to a “neutral” rating.The current price is $1.59.
Definitive Healthcare (NASDAQ:DH) was downgraded by analysts at BTIG Research from a “buy” rating to a “neutral” rating.The current price is $4.00.
Expedia Group (NASDAQ:EXPE) was downgraded by analysts at Piper Sandler from a “neutral” rating to an “underweight” rating. They now have a $135.00 price target on the stock. This represents a 13.0% downside from the current price of $155.18.
First Advantage (NYSE:FA) was downgraded by analysts at Royal Bank of Canada from an “outperform” rating to a “sector perform” rating. They now have a $20.00 price target on the stock. This represents a 12.7% upside from the current price of $17.75.
Holley (NYSE:HLLY) was downgraded by analysts at Benchmark Co. from a “buy” rating to a “hold” rating.The current price is $1.78.
International Money Express (NASDAQ:IMXI) was downgraded by analysts at BMO Capital Markets from an “outperform” rating to a “market perform” rating. They now have a $11.00 price target on the stock, down previously from $18.00. This represents a 2.2% upside from the current price of $10.76.
Iovance Biotherapeutics (NASDAQ:IOVA) was downgraded by analysts at Citizens Jmp from an “outperform” rating to a “market perform” rating.The current price is $1.80.
Kraft Heinz (NASDAQ:KHC) was downgraded by analysts at DZ Bank AG from a “buy” rating to a “hold” rating. They now have a $31.00 price target on the stock. This represents a 9.4% upside from the current price of $28.35.
Murphy USA (NYSE:MUSA) was downgraded by analysts at Raymond James from an “outperform” rating to a “market perform” rating.The current price is $431.93.
Palmer Square Capital BDC (NYSE:PSBD) was downgraded by analysts at Oppenheimer Holdings Inc. from an “outperform” rating to a “market perform” rating.The current price is $12.02.
Satixfy Communications (NYSEAMERICAN:SATX) was downgraded by analysts at Alliance Global Partners from a “buy” rating to a “neutral” rating. They now have a $2.10 price target on the stock. This represents a 3.2% upside from the current price of $2.04.
SEA (NYSE:SE) was downgraded by analysts at Bank of America Co. from a “buy” rating to a “neutral” rating. They now have a $160.00 price target on the stock. This represents a 13.0% upside from the current price of $141.61.
HF Foods Group (NASDAQ:HFFG) is now covered by analysts at Roth Capital. They set a “buy” rating and a $7.00 price target on the stock. This represents a 71.4% upside from the current price of $4.09.
Himax Technologies (NASDAQ:HIMX) is now covered by analysts at Morgan Stanley. They set an “overweight” rating and a $8.80 price target on the stock. This represents a 16.0% upside from the current price of $7.59.
Sign up for MarketBeat All Access to gain access to MarketBeat’s full suite of research tools:
Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat’s trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what’s happening in the market right now with MarketBeat’s real-time news feed. Export data to Excel for your own analysis.
